{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:25:00Z","timestamp":1794983100218,"version":"4.9.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Gallbladder and biliary tract cancer (GBTC) remains highly lethal. We examined 32-year epidemiological trends in China and projected outcomes to 2050. Using 2021 Global Burden of Disease (GBD) data, we extracted annual GBTC incident and prevalent cases, deaths, and disability-adjusted life years (DALYs) for 1990 to 2021, stratified by sex, age, and socio-demographic index (SDI). The age-standardized rates (ASRs) were calculated, and ARIMA models forecast 2050 incidence and mortality. Globally, GBTC risk rises after age 60 and correlates with SDI (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      \u2005=\u20050.588). In China, cases increased from 17,077 in 1990 to 51,720 in 2021, raising the age-standardized incidence rate (ASIR) from 2.04 to 2.49\/100,000 (+0.50% annually). Prevalent cases increased to 79,688 (age-standardized prevalence rate (ASPR) 3.77\/100,000). Conversely, ASMR fell from 2.32 to 1.85\/100,000 (\u22120.75%), and DALYs declined from 51.3 to 40.4\/100,000 (\u22120.87%), driven by fewer years of life lost (YLL). Males drove incidence and prevalence. Projections suggest male incidence will keep rising until 2050, while female rates are projected to plateau; male mortality stays stable, and female mortality continues a gradual decline. Aging and rising SDI inflate GBTC incidence, yet improved care compresses mortality. Males carry an increasing share. Targeted prevention and early detection are critical to curb incidence and improve survival.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051008","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:00:32Z","timestamp":1792173632000},"page":"e51008","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A cross-sectional analysis and forward projection of China\u2019s gallbladder and biliary-tract cancer burden"],"prefix":"10.1097","volume":"105","author":[{"given":"Ke","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-3585","authenticated-orcid":false,"given":"Youfu","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6452-2377","authenticated-orcid":false,"given":"Jianfei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shaanxi Provincial People\u2019s Hospital, Xi\u2019an, Shaanxi, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.suc.2024.04.003","article-title":"Cholangiocarcinoma.","volume":"104","author":"Harrison","year":"2024","journal-title":"Surg Clin North Am"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","article-title":"Intrahepatic cholangiocarcinoma.","volume":"28","author":"El-Diwany","year":"2019","journal-title":"Surg Oncol Clin N Am"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1007\/s00261-020-02871-2","article-title":"Current update on gallbladder carcinoma.","volume":"46","author":"Ganeshan","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1024\/0040-5930\/a001315","article-title":"Gallbladder carcinoma and extrahepatic cholangiocarcinoma.","volume":"78","author":"Seeger","year":"2021","journal-title":"Ther Umsch"},{"issue":"Suppl 1","key":"R6-20261118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/liv.14089","article-title":"Surgery for cholangiocarcinoma.","volume":"39","author":"Cillo","year":"2019","journal-title":"Liver Int"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00432-024-05975-0","article-title":"Research progress on prognostic factors of gallbladder carcinoma.","volume":"150","author":"Miao","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.12998\/wjcc.v11.i16.3694","article-title":"Application of laparoscopic surgery in gallbladder carcinoma.","volume":"11","author":"Wu","year":"2023","journal-title":"World J Clin Cases"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/pjp.2024.135860","article-title":"Tumour budding in gallbladder carcinoma.","volume":"75","author":"Rivera-Moncada","year":"2024","journal-title":"Pol J Pathol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/diagnostics13020233","article-title":"Diagnosis of cholangiocarcinoma.","volume":"13","author":"Shin","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R11-20261118","first-page":"e75142","article-title":"Newer biomarkers in gallbladder carcinoma: a scoping review.","volume":"16","author":"Upadhyay","year":"2024","journal-title":"Cureus"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular pathogenesis of cholangiocarcinoma.","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"109730","DOI":"10.1016\/j.ejso.2025.109730","article-title":"Challenging cholangiocarcinoma.","volume":"51","author":"Morement","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/sim.7344","article-title":"Improved confidence interval for average annual percent change in trend analysis.","volume":"36","author":"Kim","year":"2017","journal-title":"Stat Med"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions.","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"e052376","DOI":"10.1136\/bmjopen-2021-052376","article-title":"Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysis.","volume":"12","author":"Arhin","year":"2022","journal-title":"BMJ Open"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12876-025-04121-5","article-title":"Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046.","volume":"25","author":"Dai","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12876-025-03842-x","article-title":"Global burden of gallbladder and biliary diseases (1990-2021) with healthcare workforce analysis and projections to 2035.","volume":"25","author":"Dai","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"e16199","DOI":"10.1111\/liv.16199","article-title":"Global burden, trends, and inequalities of gallbladder and biliary tract cancer, 1990-2021: a decomposition and age-period-cohort analysis.","volume":"45","author":"Lei","year":"2025","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:00:59Z","timestamp":1794981659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051008"}},"subtitle":["Insights from the 2021 Global Burden of Disease Study"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":21,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051008","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-03-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}